Foresite Capital Management VI LLC Diversified Active

Name: Foresite Capital Management VI LLC Q1 2026 13F Filing | 13F Explorer
Creator: Foresite Capital Management VI LLC
Published: 2026-05-15

Location: West Hollywood, CA

CIK: 0002013341 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $460M (100.0% shares, 0.0% debt)

Holdings (17)

New Positions (8)

NERV Minerva Neurosciences, Inc. 2.6%

Value $11.97M Shares 1,986,600 Est. Cost $4.97 Unrealized 0.0%

CLDX Celldex Therapeutics, Inc. 2.2%

Value $10.02M Shares 315,913 Est. Cost $25.41 Unrealized 0.0%

ATAI AtaiBeckley Inc. 2.1%

Value $9.735M Shares 2,750,000 Est. Cost $3.85 Unrealized 0.0%

CRNX Crinetics Pharmaceuticals, Inc. 1.7%

Value $7.7M Shares 212,010 Est. Cost $49.21 Unrealized 0.0%

OKUR OnKure Therapeutics, Inc. 1.3%

Value $5.986M Shares 1,445,783 Est. Cost $2.73 Unrealized 0.0%

JBIO Jade Biosciences, Inc. 1.0%

Value $4.496M Shares 320,000 Est. Cost $14.79 Unrealized 0.0%

GHRS GH Research PLC 1.0%

Value $4.436M Shares 315,492 Est. Cost $15.71 Unrealized 0.0%

ZURA Zura Bio Ltd 0.6%

Value $2.678M Shares 450,000 Est. Cost $5.88 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NERV	Minerva Neurosciences, Inc.	1,986,600	$11.97M	2.6%	$4.97	0.0%	COM	603380205
CLDX	Celldex Therapeutics, Inc.	315,913	$10.02M	2.2%	$25.41	0.0%	COM	15117B202
ATAI	AtaiBeckley Inc.	2,750,000	$9.735M	2.1%	$3.85	0.0%	COM	04650F101
CRNX	Crinetics Pharmaceuticals, Inc.	212,010	$7.7M	1.7%	$49.21	0.0%	COM	22663K107
OKUR	OnKure Therapeutics, Inc.	1,445,783	$5.986M	1.3%	$2.73	0.0%	COM CL A	68277Q105
JBIO	Jade Biosciences, Inc.	320,000	$4.496M	1.0%	$14.79	0.0%	COM	008064206
GHRS	GH Research PLC	315,492	$4.436M	1.0%	$15.71	0.0%	ORD	G3855L106
ZURA	Zura Bio Ltd	450,000	$2.678M	0.6%	$5.88	0.0%	CL A	G9TY5A101

Increased Positions (3)

CRVS Corvus Pharmaceuticals, Inc. 5.8%

Value $26.79M (+151.9%) Shares 1,831,233 (+32.6%) Est. Cost $9.38 Unrealized +73.6%

DNLI Denali Therapeutics Inc. 5.0%

Value $23.23M (+40.7%) Shares 1,209,971 (+21.0%) Est. Cost $15.28 Unrealized +28.4%

HNGE Hinge Health, Inc. 1.8%

Value $8.499M (+35.5%) Shares 220,400 (+63.3%) Est. Cost $40.49 Unrealized +0.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CRVS	Corvus Pharmaceuticals, Inc.	1,831,233 (+32.6%)	$26.79M (+151.9%)	5.8%	$9.38	+73.6%	COM	221015100
DNLI	Denali Therapeutics Inc.	1,209,971 (+21.0%)	$23.23M (+40.7%)	5.0%	$15.28	+28.4%	COM	24823R105
HNGE	Hinge Health, Inc.	220,400 (+63.3%)	$8.499M (+35.5%)	1.8%	$40.49	+0.3%	CL A	433313103

Exited Positions (3)

RAPT RAPT Therapeutics, Inc. 11.5%

Value $52.92M Shares 1,562,500 Est. Cost $7.63 Unrealized +562.1%

NTRA Natera, Inc. 3.4%

Value $15.43M Shares 67,356 Est. Cost $208.59 Unrealized +8.3%

— Atai Beckley N.V. 2.4%

Value $11.25M Shares 2,750,000 Est. Cost $4.09 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
RAPT	RAPT Therapeutics, Inc.	1,562,500	$52.92M	11.5%	$7.63	+562.1%	—	75382E208
NTRA	Natera, Inc.	67,356	$15.43M	3.4%	$208.59	+8.3%	—	632307104
—	Atai Beckley N.V.	2,750,000	$11.25M	2.4%	$4.09	—	—	N0731H103

Unchanged Positions (6)

CGON CG Oncology, Inc. 32.7%

Value $150M Shares 2,221,474 Est. Cost $34.21 Unrealized +53.2%

ALMS ALUMIS INC. 20.3%

Value $93.58M Shares 4,247,670 Est. Cost $9.97 Unrealized +144.0%

CNTA Centessa Pharmaceuticals plc 11.8%

Value $54.18M Shares 1,364,019 Est. Cost $17.39 Unrealized —

VSTM Verastem, Inc. 3.6%

Value $16.68M Shares 3,146,631 Est. Cost $7.21 Unrealized -10.1%

AGIO AGIOS PHARMACEUTICALS, INC. 3.9%

Value $17.76M Shares 525,000 Est. Cost $35.08 Unrealized -20.1%

KYMR Kymera Therapeutics, Inc. 2.6%

Value $12.19M Shares 146,332 Est. Cost $45.17 Unrealized +71.8%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG Oncology, Inc.	2,221,474	$150M	32.7%	$34.21	+53.2%	COM	156944100
ALMS	ALUMIS INC.	4,247,670	$93.58M	20.3%	$9.97	+144.0%	COM	022307102
CNTA	Centessa Pharmaceuticals plc	1,364,019	$54.18M	11.8%	$17.39	—	SPONSORED ADS	152309100
VSTM	Verastem, Inc.	3,146,631	$16.68M	3.6%	$7.21	-10.1%	COM	92337C203
AGIO	AGIOS PHARMACEUTICALS, INC.	525,000	$17.76M	3.9%	$35.08	-20.1%	COM	00847X104
KYMR	Kymera Therapeutics, Inc.	146,332	$12.19M	2.6%	$45.17	+71.8%	COM	501575104